GUPTA SHALABH K. enters UNICYCIVE THERAPEUTICS, INC. with 5.77M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 7/12/2021ACC: 0001493152-21-016656
DirectorOfficer· CEO & President
Since Jul 2021
5.77M
Baseline shares
40% direct
2.32M
Direct ownership
1 position
101.74K
Derivative underlying
1 instrument
4
Security positions
3.45M indirect
Non-Derivative Holdings4
Common Stock
IndirectShares owned69.77K
Common Stock
IndirectShares owned1.47M
Common Stock
DirectShares owned2.32M
Common Stock
IndirectShares owned1.90M
Total
2.32M direct·3.45M indirect5.77M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 69.77K | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 2.32M | Direct |
| Common Stock | 1.90M | Indirect |
| Total | 5.77M | 2.32M direct·3.45M indirect |
Derivative Holdings1
Employee Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
101.74K
Shares owned
N/A
Exercise price
0.01
Expiration
—
Exercise window
—
Total
Underlying
101.74K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock | 0.01 | — | — | 101.74K | N/A |
| Total | 101.74K | 0.00 | ||||